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Decreasing bladder cancer mortality in the Netherlands
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Objective To evaluate the prediction that the observed 
increasing trend in male bladder cancer mortality in
the Netherlands 1.955 and 1988 would
change to a decreasing trend.
Materials and methods Using demographic and mor­
tality data from the Netherlands Central Bureau of 
Statistics, male and female bladder cancer mortality 
per 105 person-years from 1955 to 1994 were calcu­
lated. Changes in structure of the Dutch 
population were adjusted using direct standardization 
to the European ‘standard’ population. The effects of 
age, calendar period and birth cohort on the temporal 
trend in mortality were evaluated using log-linear 
modelling.
Results Male mortality from bladder cancer increased 
from 6.2 per 1 0 s in 1955 to 12.6 per 105 in 1990, 
but decreased thereafter. Female mortality from blad-
der cancer has remained stable throughout the study 
period, at 2.8 and 2.7 per 1 0 s in 1955 and 1994,
. The changing trend among men is con­
sistent with an increasing risk for successive birth
1910 cohort and a decreasing risk
for cohorts born 1930.
probably caused by changes in the i 
of the mt
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maviour
were no
in risk lor successive
Conclusion Male mortality from bladder cancer in the 
Netherlands will probably decrease for at least another 
decade. A future increase in female mortality from 
bladder cancer, as recorded for lung cancer, is unlikely.
Keywords Bladder, neoplasms, mortality, smoking, 
epidemiology
Introduction Materials and methods
in the Netherlands, the Central Bureau of Statistics (CBS)
has registered un
In a previous paper [1] we reported the results from an 
analysis of bladder cancer mortality data from the 
Netherlands. In females, there was no change in the risk 
of dying from bladder cancer throughout the study 
period (1 9 5 5 -1 9 8 8 ); in contrast, there was an increas­
ing trend for males over the same period. When analysed 
using a log-linear model, it appeared that this increasing 
trend was caused by a higher risk of dying from bladder 
cancer in successive birth cohorts rather than by a
risk in successive calendar years. The risk of the ICD-code 181.0, and for 
dying from bladder cancer increased from the 1875
causes of death since 1900
The number of men and women with bladder cancer 
recorded as the cause of death, as well as the age- and
of the Dutch population, were 
abstracted from the annual publications of the CBS for 
the years 19 55 to 1994 inclusive [2,3|. In this period, 
four revisions of the International Classification of 
Diseases were used; for the sixth and seventh revisions,
and ninth
revisions, the ICD-code 188, were used as the delinitions
birlh-cohort the 191.0 birlh-cohort; the risk of bh ' cancer. For statistical analysis the nu rs of
to i,’,,,ease from 19 3 0 -c
although this decreasing risk was not apparent in 
mortality trend. It was predicted that mortality from 
male bladder cancer would decrease when more mem­
bers of this younger generation reached an age with a 
higher risk from bladder cancer. Thus in the present 
study we re-evaluated the temporal trends in male and 
female bladder cancer mortality using data collected up
to 1994.
ratei’
deaths from bladder cancer were categorized in 5-year
s and 5-year calendar periods of registration; 
10 s person-years based on these values are 
in Tables 1 and 2. The population aged < 3 5  
years were ignored because mortality from this disease is
group. Birth cohorts were delined by combin­
ing age and calendar periods (see step-lines in 'fables I
rare m
and 2). To
cancer in
mortality rates from bladder 
:ir years, the change in age 
distribution of the Dutch population was adjusted using 
direct standardization to (he European standard
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Table I Age-speeiiic bladder cancer mortality rates per 10 0 0 0 0  man-years in the Netherlands, 1 9 5 5 -1 9 9 4 .
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Table 2 Age-specilic bladder cancer mortality rates per 1 0 s woman-years in the Netherlands, 1 9 5 5 -1 9 9 4 .
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on mortality of the 
were titled so that their combination in all age- and
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period-specitic groups in Table 1 were as close to the 
observed rates as possible, using the maximum likelihood
method in the software package GLIM.
To test the goodness-of-lit of the models with the 
observed mortality rates, and to test the models against 
each other, the x 2 approximation to the — 2 In (likeli- 
hood-ratio) was used; the techniques of log-linear model­
ling for the analysis of temporal variation in cancer have 
been described previously [4, 5].
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Results
From 1955 to 1990, male age-standardized bladder 
cancer mortality rates per 105 person-years rose from 
6.2 to 12.6. After 1990, the risk decreased significantly 
to 10.4 per 105 (Fig. 1). By contrast, female bit 
cancer mortality remained stable throughout the study
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Age
period; in 1955, 2.8 women per 10
Fig. 2. Age-.specilk bladder cancer mortality for successive male 
birth cohorts. Dark green, 1870. Light green, 1880. Light red, 
1890. Dark red, 1990. Dashed dark green, 1910. Dashed light
cancer and in 1994, the mortality rate was 2.7 per green, 1920. Dashed light red, 1930. Dashed dark red, 1940.
10s.
The increasing trend in men appears to originate from 
a higher risk of dying from bladder cancer in successive 
birth cohorts, as shown in Fig, 2, where the oldest birth 
cohorts are represented by lines in the right-lower part of 
the graph. Younger birth cohorts have a higher risk and 
are therefore shifted to the left and upper part of the 
graph. However, the youngest birth cohorts do not have 
a higher risk compared with the 1910 cohort.
From log-linear modelling of male bladder cancer 
mortality rates, in addition to the effect of age, the 
temporal trend cannot be explained sufficiently by 
either an effect of the calendar period alone or an effect 
of birth cohort alone.
Table 3 GLIM statistics for male bladder cancer mortality in the 
Netherlands (1 9 5 5 -1 9 9 4 )
Model Deviance d.f. P
(1) Age* 598.6 70 0.000
(2) Age +  period 2 30.4 63 0.000
(3) Age+ cohort 82.9 54 0.007
(4) Age +  period +  cohort 46 .4 48 0.538
(5) Mode] 4 vs model 3 36.5 6 0.000
though the age-
model seemed to lit better than the age-period model, 
only the full age-period-cohort model gave an adequate 
description of the data (Table 3). The disadvantage of
"The age model describes the situation in which rates are predicted 
by age factors only and represents the null hypothesis of no 
temporal trend
this age-period-cohort model is that no unique solution
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imeter estimates, i.e.
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arbitrarily and period effect was
Taking the first period ( 1 9 5 5 - 1 9 5 9 )  as a reference, the 
relative risks of dying from bladder cancer in more 
recent periods appear to be close to unity (Fig. 3).
Apparently, there is a statistically significant but quanti-
insignilicant period birth
cohorts to have higher risks until the
1n  i I I 1.1 I. ..I 1 .1.1 j I I I I I I I I I-I. i l i  I I i I I I I I I I I I I 10
1955 1960 1965 1970 1975 1980 1985 1990 1995
cohort, which was taken as the reference. The younger 
birth cohorts appear to have lower risks, except lor the 
last two; however, the 1950  and 1955 birth-cohort
Fig. 1. Trend in bladder cancer mortality in the Netherlands effects are based on only two and one mortality rates,
between 1955 and 1994 (age-standardized to the European respectively, in relatively young men (aged < 4 5  years)
standard population). Green, men. Red, women. which makes the interpretation
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lJig. 3. Relative risk of male bladder cancer mortality in the 
Netherlands according to year of birth and registration period. 
Green, cohort effects. Red, Period effects.
Netherlands since 1987  [7]. However, the risk of lung 
cancer for women has been increasing since 1970  
because risks are increasing for successive female birth 
cohorts. In the Netherlands, the proportion of smokers 
amongst the adult female population increased to 42% 
in 1967  and decreased to 29% in 1994 (Fig. 4). Because 
of the later age of onset for lung cancer, female lung 
cancer mortality rates will probably increase foi 
two decades before they undergo a decline similar to 
that in males.
Why is an increasing trend not seen in female bladder 
cancer mortality? Without doubt, the most important
reason is the aetiological fraction of s ing for lung
and bladder cancer. It is estimated that about 90% of all 
lung cancers are caused by smoking, whereas it causes 
only 30-40%  of all bladder cancers [8|. Theoretically, 
differences in survival from lung cancer and bladder 
cancer provide another explanation. Because the fatality
Discussion
Since 1990, there has been a decline in the risk of death 
from bladder cancer among Dutch men and this decline 
was predicted in an earlier report, where the risks for 
male birth cohorts after 1930  were found to be decreas­
ing [1]. This decreasing risk for younger male gener­
ations is probably caused by changes in smoking 
behaviour in the Netherlands. According to annual 
surveys of 1 0 -2 0  0 0 0  Dutch men by the Foundation for 
Public Health and Smoking, the use of tobacco products 
became very popular in the first half of this century. In 
1958, 90% of the male adult ( ^  15 years old) population 
were smokers (Fig. 4) and this decreased to 36% in 1994  
[6|. However, it has taken more than 30 years for the 
change in smoking behaviour to become apparent in the 
rates of mortality from bladder cancer.
In accordance with the trend in bladder cancer, there
cancer mortality in thehas been a in
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Fig. 4. Percentage of smokers among Dutch adult males and 
females (from f6|). Green, men, Red, women.
rate from lung cancer is extremely high, it 
matter whether the incidence or mortality data for lung 
cancer are used in trend studies, but the fatality rate for 
bladder cancer is much lower. Therefore, the effects of 
trends in smoking behaviour might be obscured when 
mortality rather than incidence data are used. In a study 
using data in a cancer registry from the south-eastern 
Netherlands, there was a very small increase in the 
incidence of muscle-invasive bladder cancer between 
1975 and 1989 [9]; however, despite such a small 
increase in incidence, the birth-cohort-specilic risks (data 
not shown) suggested that, contrary to female lung 
cancer mortality, female bladder cancer mortality will 
not increase in the future.
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